Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Polycystic Ovary Syndrome (PCOS)
NCT02663570Unknown
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of melatonin in polycystic ovary syndrome (PCOS), sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: Number of menstrual cycles in six months of therapy at 6 months. Status: unknown.
02
Drugs
melatonin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02663570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02663570.